European Pharmaceutical Review

JUNE 12, 2025

These factors have created an ecosystem that allows MLM to address the challenges of drug development. The automatic generation of molecular structures accelerates drug candidate design by predicting target affinity. Through increased efficiency, MLMs can lower drug development costs.

Drug Development 52

Drug Development Documentation Labelling Diabetes 52

PharmaVoice

JULY 1, 2025

Published July 1, 2025 By Alexandra Pecci post share post print email license Stock via Getty Images Listen to the article 6 min This audio is auto-generated. For example, the company engages its patient advisory councils “on topics across the full continuum of drug development, from discovery to commercialization.”

Drug Development 205

Drug Development 205

Pharmaceutical Technology

JUNE 24, 2025

Login Registration is disabled.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies 52

Pharma Times

JULY 22, 2025

The data supports the platform’s potential to accelerate drug development programmes and expand the druggable proteome. Dr Benedict Cross, CTO, PhoreMost, said: “Molecular glues have now been established as an effective therapeutic modality, but these small molecule drugs have still largely only been found through serendipity.

Drug Development 82

Drug Development 82

PharmaVoice

JULY 9, 2025

Published July 9, 2025 Amy Baxter Staff Reporter post share post print email license Stock via Getty Images Listen to the article 6 min This audio is auto-generated. What’s on Steiner’s to-do list for the rest of 2025? Please let us know if you have feedback.

Vaccines 244

Vaccines Immunity Immunization Drug Development 244

LifeProNow

FEBRUARY 2, 2025

January 30, 2025: “The U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Adverse Reactions 130

Adverse Reactions Labelling Drug Development 130

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

European Pharmaceutical Review

JUNE 19, 2025

1,2,3 The reflection paper is currently open for public consultation, inviting feedback from stakeholders across the pharmaceutical sector until 30 September 2025. 1,2 EMA’s draft reflection paper – implications for drug developers and manufacturers The proposed tailored approach offers opportunities for developers and manufacturers.

Biosimilars 97

Biosimilars Packaging Documentation Drug Development 97

FDA Law Blog: Biosimilars

APRIL 8, 2025

Leading FDAs implementationof the Drug Competition Action Plan (DCAP). The DCAP was an initiative launched in 2017 to remove barriers to generic drug development, approval, and market entry (see our previous post here ). Overseeing the development, clearance, and issuance of every policy document FDA issued on generic drugs.

Documentation 144

Documentation Labelling Drug Development 144

Express Pharma

DECEMBER 2, 2024

Additionally, Novo Nordisk’s novel Phase III candidate, NN-9932, which is expected to be launched by the end of 2025, has the highest probability of success among all drugs in this category, with a 35 per cent likelihood of approval (LoA).” Novo Nordisk and Eli Lilly have already reaped substantial rewards in the injectable segment.

Labelling 126

Labelling Diabetes Drug Development 126

PharmaVoice

JUNE 6, 2025

Published June 6, 2025 Michael Gibney Senior Editor & Writer post share post print email license Permission granted by Daiichi Sankyo Listen to the article 8 min This audio is auto-generated. By Amy Baxter • June 5, 2025 Keep up with the story. © 2025 TechTarget, Inc. Please let us know if you have feedback.

Chemotherapy 148

Chemotherapy Drug Development 148

Pharmaceutical Technology

JUNE 26, 2025

Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. Addressing data gaps and biases in AI training is crucial for drug development.

Compounding 86

Compounding Drug Development Communication Packaging 86

Pharmacy Times

JULY 22, 2025

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. The FDA plan seeks to leverage existing new technology in drug development. 3,6 REFERENCES FDA drug approval process infographic (horizontal).

Pharmacy Technician 20

Pharmacy Technician Compounding Immunity Immunization 20

PharmaTech

JUNE 19, 2025

Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. June 17, 2025. Pharmaceutical Technology 2025 49 (4). Drug Digest: Securing the Supply Chain for Small-Molecule APIs and Excipients. Press Release.

Dosage 59

Dosage Drug Development Packaging Communication 59

Express Pharma

MARCH 16, 2025

First, advanced research and development (R&D) and biologics will be critical. To move from generics to novel drug development, Indian companies must invest heavily in R&D for innovative therapies like biosimilars, cell and gene therapies, and specialty drugs.

Biosimilars 110

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 110

Express Pharma

APRIL 8, 2025

To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.

Pharmaceutical Manufacturing 76

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Drug Development 76

Putting Patients First Blog

JUNE 9, 2025

Another shared that “The NHC consistently delivers value, and the 2025 Science of Patient Engagement Symposium was no exception. It was the perfect blend of information, inspiration, and interaction.” To learn more about the Symposium and sessions, you can access the Attendee Evaluation Results report HERE.

Hospitals 52

Hospitals Drug Development 52

Pharmacy Times

JULY 22, 2025

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. Accessed July 21, 2025. Accessed July 21, 2025. Accessed July 21, 2025. European Medicines Agency. link] NHS England.

Pharmacy Technician 20

Pharmacy Technician Insurance Coverage and Processing Compounding Pharmacies Diabetes 20

Putting Patients First Blog

JUNE 26, 2025

Rutta Chief Executive Officer 1 Centers for Medicare & Medicaid Services, “Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request,” Federal Register 90, no. 95 (May 15, 2025): 20674, https ://www.federalregister.gov/d/2025-08607. McLoughlin et al., 10 Julie A.

Drug Pricing 52

Drug Pricing Communication Drug Development Documentation 52

Pharma Leaders

JULY 15, 2025

Regulatory bodies are grappling with how to oversee AI in drug development, emphasizing the need for human oversight and accountability in AI-driven decisions. Source: Pharma Voice | July 1, 2025

Drug Development 71

Drug Development 71

Pharma Leaders

JULY 2, 2025

Bridging the Information Gap There’s a growing information gap between drug developers, doctors, and patients. Source: Medical Marketing and Media | June 27, 2025 Old-school pamphlets are being replaced by digital content to keep pace with both in-person and virtual care.

Communication 40

Communication Drug Development 40

RX Note

JUNE 12, 2025

Information for Patients Patients in whom an allergic reaction to a drug develops should be educated as to the name of the specific drug, the terminology used to describe the reaction, and the likelihood of having a similar or more severe reaction upon re-exposure to the drug. Patient self-reported absence of an allergy.

Adverse Reactions 52

Adverse Reactions Immunity Immunization Drug Development 52

pharmaphorum

JUNE 16, 2025

At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle.

Drug Development 52

Drug Development 52

PharmaTech

JUNE 19, 2025

By further supporting high-potential start-ups and contributing to cutting-edge medical technology development, we can continue to play an active role in the delivery of meaningful improvements to patient outcomes.” June 12, 2025. Industry Outlook 2025: European Geopolitical Impact on Pharma. PharmTech.com , May 8, 2025.

Dosage 52

Dosage Drug Development Packaging 52

Pharmacy Times

JUNE 23, 2025

CMS is issuing unique J-codes for 505(b)(2) drugs, classifying them as sole-source products if not therapeutically equivalent. This pathway reduces submission denial risk, accelerates drug development, and offers potential market exclusivity for up to 7 years. 505(b)(2) drugs: new chaos for infusion centers.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.

Drug Development 52

Drug Development Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 19, 2025

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

PharmaVoice

JUNE 16, 2025

Published June 16, 2025 Amy Baxter Staff Reporter post share post print email license Arkansas Gov. Arkansas became the first state in the nation to ban PBMs from owning pharmacies in 2025. Massachusetts, Missouri, North Dakota and Utah have also enacted reforms related to PBM contracts in the first half of 2025.

Drug Pricing 306

Drug Pricing Independent Pharmacies Community Pharmacies Drug Development 306

European Pharmaceutical Review

DECEMBER 19, 2024

For] AI use in life sciences R&D… 2025 will see the industry enter the “plateau of enlightenment” AI use in life sciences R&D has now passed through most major stages of the Gartner Hype Cycle 2 and 2025 will see the industry enter the “plateau of enlightenment.” Computers in Biology and Medicine.

Drug Development 98

Drug Development 98

PharmaTech

JUNE 9, 2025

Challener News Article Pharmaceutical Technology Pharmaceutical Technology June 2025 Volume 49 Issue 5 Unique surface properties and ligand functionalization provide real advantages. Efficient and effective delivery of complex and challenging drug substances is an ongoing issue facing developers of modern medicines. 2025 19 (4).

Dosage 52

Dosage Drug Development Immunity Immunization 52

Pharmacy Times

JUNE 19, 2025

SHOW MORE With robust pipelines, cell therapy remains the major driver for drug development. 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. Accessed January 17, 2025. Accessed February 2025. March 6, 2025. Accessed May 12, 2025. Accessed January 15, 2025.

Pharmacy Technician 26

Pharmacy Technician Diabetes Compounding Compounding Pharmacies 26

The Nontraditional Pharmacist

JULY 1, 2025

It’s 2025. And there’s master’s programs, for example, I have an academic appointment at University of Cincinnati and they have a master’s of drug development program, which is fantastic. So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. So, we would have spoken in 2019.

Hospitals 52

Hospitals Packaging Documentation Labelling 52

Express Pharma

JUNE 12, 2025

link] 019-0050-7 Akums Drugs & Pharmaceu- ticals Ltd. 2025, May 10). The collab- oration between industry and academia in drug development. link] collaboration-between-indus- try-and-academia-in-drug-de- velopment/ Singh, N., Frontiers in Drug Discovery, 3, Article 1201419. 2024, December). Rathbone, A.

Clinical Pharmacology 59

Clinical Pharmacology Drug Development Dosage Compounding 59

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52

PharmaTech

JUNE 11, 2025

Image Credit: © Anne Czichos - stock.adobe.com Simtra BioPharma Solutions, a sterile injectables contract development and manufacturing organization out of Bloomington, Ind. Simtra BioPharma Solutions and MilliporeSigma Announce Strategic Alliance for Antibody Drug Conjugates Drug Substance and Drug Product Manufacturing Services.

Dosage 52

Dosage Drug Development Compounding Vaccines 52

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines 52

Vaccines Pharmaceutical Manufacturing Communication Hospitals 52

Pharma Marketing Network

MAY 11, 2025

Drug Price Cuts and Policy Impact The Biden administrations Inflation Reduction Act (IRA), passed in 2022 and implemented in phases since, empowers Medicare to negotiate the prices of selected high-cost prescription drugs. exports or licensing agreements with U.S. How should Asian pharma brands respond to this trend? Absolutely.

Drug Pricing 59

Drug Pricing Biosimilars Communication Pharmaceutical Companies 59